Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Stomach Neoplasms 38Pancreatic Neoplasms 11Esophageal Neoplasms 8Biliary Tract Neoplasms 8Colorectal Neoplasms 7Neoplasm Metastasis 3Gastrointestinal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Carcinoma, Non-Small-Cell Lung 3Advanced Solid Tumors 3Neoplasms 2Head and Neck Neoplasms 2Colonic Neoplasms 2Cholangiocarcinoma 2Advanced Non-Small Cell Lung Cancer 2Advanced Gastric Cancer 2Adenocarcinoma 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Progression Free Survival 1Patients With Advanced or Metastatic Solid Tumors 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Overall Survival 1Nasopharyngeal Carcinoma 1Hand-Foot Syndrome 1Carcinoma, Transitional Cell 1Breast Neoplasms 1Advanced Pancreatic Cancer 1Adenocarcinoma Of Esophagus 1

Interventions

pembrolizumab 25Gemcitabine 21Nivolumab 17Cisplatin 17atezolizumab 14Carboplatin 11avelumab 9vinflunine 7Ipilimumab 7Paclitaxel 6Docetaxel 5enfortumab vedotin 4cabazitaxel 4Pemetrexed 4Mitomycin 4cabozantinib 3Taxes 3Rogaratinib 3Magnetic Resonance Spectroscopy 3Injections 3Albumin-Bound Paclitaxel 3tremelimumab 2sacituzumab govitecan 2pemigatinib 2niraparib 2lenvatinib 2bempegaldesleukin 2apatorsen 2XRP6258 2Vitamin D 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoma, Transitional Cell × S 1 (combination) × Clear all
NCT03051373 2021-08-09

Phase 2 Trial of Nab-paclitaxel Plus S-1 vs Gemcitabine Plus Cisplatin as 1-line Chemotherapy of Patients With Local Advanced and/or Metastatic Transitional Cell Carcinoma of Urothelial Tract

Chinese PLA General Hospital

Phase 2 Completed
108 enrolled
Genitourinary

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡